Your browser doesn't support javascript.
loading
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Barlesi, Fabrice; Vansteenkiste, Johan; Spigel, David; Ishii, Hidenobu; Garassino, Marina; de Marinis, Filippo; Özgüroglu, Mustafa; Szczesna, Aleksandra; Polychronis, Andreas; Uslu, Ruchan; Krzakowski, Maciej; Lee, Jong-Seok; Calabrò, Luana; Arén Frontera, Osvaldo; Ellers-Lenz, Barbara; Bajars, Marcis; Ruisi, Mary; Park, Keunchil.
Afiliação
  • Barlesi F; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France.
  • Vansteenkiste J; Department of Respiratory Oncology, University Hospital KU Leuven, Leuven, Belgium.
  • Spigel D; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Ishii H; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
  • Garassino M; Thoracic Oncology Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • de Marinis F; Thoracic Oncology Division, European Institute of Oncology, Milan, Italy.
  • Özgüroglu M; Department of Internal Medicine, Division of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Szczesna A; Department of Lung Diseases, Regional Lung Disease Hospital, Otwock, Poland.
  • Polychronis A; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex, UK.
  • Uslu R; Ege University Hospital, Department of Medical Oncology, Izmir, Turkey.
  • Krzakowski M; Centrum Onkologii-Instytut Im M Sklodowskiej-Curie w Warszawie, Warsaw, Poland.
  • Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Calabrò L; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy.
  • Arén Frontera O; Centro Investigación Clínica Bradford Hill, Santiago, Chile.
  • Ellers-Lenz B; Merck, Darmstadt, Germany.
  • Bajars M; EMD Serono, Billerica, MA, USA.
  • Ruisi M; EMD Serono, Billerica, MA, USA.
  • Park K; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: kpark@skku.edu.
Lancet Oncol ; 19(11): 1468-1479, 2018 11.
Article em En | MEDLINE | ID: mdl-30262187
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Docetaxel / Neoplasias Pulmonares / Anticorpos Monoclonais / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Docetaxel / Neoplasias Pulmonares / Anticorpos Monoclonais / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França